Published Date: 20-11-2018
Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support
According to a new report Asia Pacific Antimicrobial Coatings Market, published by KBV research, the Asia Pacific Antimicrobial Coatings Market would witness market growth of 15.8% CAGR during the forecast period (2018 – 2024).
The Japan held the largest share in the Asia Pacific Antimicrobial Coatings Market in 2017. The India market is expected to grow at the fastest pace during (2018 – 2024).
The metallic coating segment contributed the larger revenue share to the India Antimicrobial Coatings Market in 2017, and would continue to be a dominant market till 2024 and is expected to grow at a CAGR of 18.3% during the forecast period. However, non-metallic coating segment is expected to grow at significant CAGR of 19.3% over the forecast period.
Orthopedic implants is a lucrative segment based on type and witnessed a significant CAGR during the forecast period owing to the rapid rise in geriatric population, who are more prone to have various orthopedic disorders.
Polymeric based non-metallic coatings dominated the market in 2017 and projected to retain its dominance by 2024; thereby, growing at a CAGR of 15.8% during (2018-2024). Polymeric based antimicrobial coatings are the potential biomaterial with antimicrobial properties that controls microbial infections.
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the countries in the region. The key impacting factors of the Asia-Pacific Antimicrobial Coatings Market have been discussed in the report with the elaborated company profiles of AAP Implantate Ag, AST Products, Inc., Specialty Coating Systems, Inc., Biocote Limited, Bayer Ag, Covalon Technologies Ltd., Dot GmbH, Koninklijke Dsm N.V., Hydromer Inc, and Harland Medical Systems, Inc.